Insiders · FRTX

FRTX insider transactions

Fresh Tracks Therapeutics Inc. (FRTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

FRTX insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Fresh Tracks Therapeutics Inc., latest first. Follow anyone to get their next filing.

• Exploration Capital, LLC10% owner+$1M
• Aaron Fox-CollisVP of Finance & CAO, since January 2023-$98.32
• Albert N Marchio IICEO and CFO, Director
• Deepak ChadhaOfficer
• Exploration Capital Fund, LP10% owner, since November 2023
• Andrew D SklawerOfficer
• David R. McAvoyOfficer

Recent Form 3, 4, and 5 filings for FRTX

• 885d
  Large owner Exploration Capital, Llc bought $381,170 worth of shares (405,500 units at $0.94) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 896d
  Exploration Capital, Llc bought $9,580 worth of shares (10,434 units at $0.92) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 904d
  Exploration Capital, Llc bought $20,821 worth of shares (22,889 units at $0.91) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 907d
  Exploration Capital, Llc bought $68,592 worth of shares (74,565 units at $0.92) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 919d
  Exploration Capital, Llc bought $285 worth of shares (320 units at $0.89) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 924d
  Exploration Capital, Llc bought $151,680 worth of shares (164,897 units at $0.92) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 934d
  Exploration Capital, Llc bought $19,421 worth of shares (21,528 units at $0.90) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 946d
  Exploration Capital, Llc bought $2,805 worth of shares (3,188 units at $0.88) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 952d
  Exploration Capital, Llc bought $15,814 worth of shares (17,378 units at $0.91) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 956d
  Exploration Capital, Llc bought $49,113 worth of shares (54,574 units at $0.90) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 967d
  Exploration Capital, Llc bought $270 worth of shares (297 units at $0.91) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 975d
  Exploration Capital, Llc bought $14,951 worth of shares (16,329 units at $0.92) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 989d
  Exploration Capital, Llc bought $18,098 worth of shares (20,109 units at $0.90) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 995d
  Exploration Capital, Llc bought $68,665 worth of shares (77,404 units at $0.89) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1031d
  Exploration Capital, Llc bought $19,686 worth of shares (19,996 units at $0.98) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1037d
  Exploration Capital, Llc bought $50,472 worth of shares (51,502 units at $0.98) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1039d
  SEC Form 4 filed by Fox-Collis Aaron

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1039d
  SEC Form 4 filed by Marchio Albert N Ii

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1043d
  Exploration Capital, Llc bought $70,413 worth of shares (78,502 units at $0.90) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1059d
  Exploration Capital, Llc bought $39,480 worth of shares (47,000 units at $0.84) (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1068d
  Chadha Deepak converted options into 35,000 shares and covered exercise/tax liability with 14,978 shares, increasing direct ownership by 874% to 22,314 units (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1068d
  Fox-Collis Aaron sold $67 worth of shares (74 units at $0.91), closing all direct ownership in the company (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1073d
  SEC Form 4 filed by Exploration Capital Fund, Lp

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1073d
  New insider Exploration Capital Fund, Lp claimed ownership of 670,000 shares (SEC Form 3)

  3 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1075d
  Fox-Colis Aaron sold $31 worth of shares (36 units at $0.85), decreasing direct ownership by 33% to 74 units (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1078d
  New insider Fox-Colis Aaron claimed ownership of 110 shares (SEC Form 3)

  3 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1136d
  Sklawer Andrew D converted options into 55,000 shares and covered exercise/tax liability with 20,833 shares, increasing direct ownership by 670% to 39,269 units (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1136d
  Mcavoy David R. converted options into 20,000 shares and covered exercise/tax liability with 7,358 shares, increasing direct ownership by 370% to 16,061 units (SEC Form 4)

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1387d
  SEC Form 4 filed by Mcavoy David R.

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1387d
  SEC Form 4 filed by Sklawer Andrew D

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1387d
  SEC Form 4 filed by Marchio Albert N Ii

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
• 1387d
  SEC Form 4 filed by Chadha Deepak

  4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)